Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer-Reference-Cited by-同舟云学术

Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

Published:2005-05 Issue:1 Volume:91 Page:61-71
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Moureau-Zabotto L.,Bouchet C.,Cesari D.,Uzan S.,Lefranc J.-P.,Antoine M.,Genestie C.,Deniaud-Alexandre E.,Bernaudin J.-F.,Touboul E.,Fleury-Feith J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-004-7047-1.pdf

Reference35 articles.

1. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre

2. Flow cytometry in node-positive breast cancer: Cancer and leukemia group B protocol 8869

3. S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

4. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.

5. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy;Cancer Biology and Medicine;2021

2. Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers;Molecular Diagnosis & Therapy;2019-08-01

3. Metastatic and triple-negative breast cancer: challenges and treatment options;Drug Delivery and Translational Research;2018-07-05

4. Assessment and Designation of Breast Cancer Stage;The Breast;2018

5. DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases;Oncotarget;2016-08-09